Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tate

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
NPJ Precision Oncology|July 29, 2022
A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironmentR C Cornelison, J X Yuan, K M Tate, et al.
Nature Communications|July 1, 2026
Dual activation of NLRP3 and pyrin inflammasomes mediates host responses to the human fungal pathogen CoccidioidesKa Pui Sharon Yau, Jonathan Rodrigo Erlich, Priscila Rodriguez, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
S1PR3 mediates glial stimulated tumor invasion in response to interstitial fluid flowR Chase Cornelison, Samantha Howerton, Kinsley M Tate, et al.
Oncogene|October 9, 2019
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variantVeronica Veschi, Laura R Mangiapane, Annalisa Nicotra, et al.
Science Translational Medicine|October 27, 2021
Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patientsPauline P Chen, Alma-Martina Cepika, Rajni Agarwal-Hashmi, et al.
American Journal of Public Health|February 1, 1971
Report of the committee on environment, 1970W E Gilbertson, R Angelotti, C M Berry, et al.
Frontiers in Oncology|April 4, 2022
Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 TherapyAlexandra R Harris, Savieay Esparza, Mohammad S Azimi, et al.
Nature Communications|July 11, 2024
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis BullosaGernot Neumayer, Jessica L Torkelson, Shengdi Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2020
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I StudyKaren A Autio, Christopher A Klebanoff, David Schaer, et al.
Genomics|June 18, 2005
High-density single-nucleotide polymorphism maps of the human genomeRaymond D Miller, Michael S Phillips, Inho Jo, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
NPJ Precision Oncology|July 29, 2022
A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironmentR C Cornelison, J X Yuan, K M Tate, et al.
Nature Communications|July 1, 2026
Dual activation of NLRP3 and pyrin inflammasomes mediates host responses to the human fungal pathogen CoccidioidesKa Pui Sharon Yau, Jonathan Rodrigo Erlich, Priscila Rodriguez, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
S1PR3 mediates glial stimulated tumor invasion in response to interstitial fluid flowR Chase Cornelison, Samantha Howerton, Kinsley M Tate, et al.
Oncogene|October 9, 2019
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variantVeronica Veschi, Laura R Mangiapane, Annalisa Nicotra, et al.
Science Translational Medicine|October 27, 2021
Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patientsPauline P Chen, Alma-Martina Cepika, Rajni Agarwal-Hashmi, et al.
American Journal of Public Health|February 1, 1971
Report of the committee on environment, 1970W E Gilbertson, R Angelotti, C M Berry, et al.
Frontiers in Oncology|April 4, 2022
Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 TherapyAlexandra R Harris, Savieay Esparza, Mohammad S Azimi, et al.
Nature Communications|July 11, 2024
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis BullosaGernot Neumayer, Jessica L Torkelson, Shengdi Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2020
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I StudyKaren A Autio, Christopher A Klebanoff, David Schaer, et al.
Genomics|June 18, 2005
High-density single-nucleotide polymorphism maps of the human genomeRaymond D Miller, Michael S Phillips, Inho Jo, et al.
Pageof 17